(Q37851481)

24 August 2017

1 reference

title

Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering (English)

1 reference

24 August 2017

1 reference

Mario Marzilli

1

1 reference

24 August 2017

publication date

1 January 2010

1 reference

American journal of cardiovascular drugs

24 August 2017

published in

1 reference

24 August 2017

volume

10 Suppl 1

1 reference

24 August 2017

page(s)

3-9

1 reference

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Non-atheroprotective effects of statins: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Jupiter to earth: a statin helps people with normal LDL-C and high hs-CRP, but what does it mean?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Statin therapy and risks for death and hospitalization in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Class effects of statins in elderly patients with congestive heart failure: a population-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Rosuvastatin in older patients with systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Effects of statin therapy on preventing atrial fibrillation in coronary disease and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Effect of statin dose on incidence of atrial fibrillation: data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) and Aggrastat to Zocor (A to Z) trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Effect of rosuvastatin on C-reactive protein and renal function in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Effect of statins on the development of renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Renoprotective effect of preoperative statins in coronary artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Statin use reduces decline in lung function: VA Normative Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

The use of statins and lung function in current and former smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Simvastatin initiated early after heart transplantation: 8-year prospective experience

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombol

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Pleiotropic effects of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Influence of statin use on endothelial function: from bench to clinics.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Effects of statins on endothelium and endothelial progenitor cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

The pravastatin inflammation CRP evaluation (PRINCE): rationale and design

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Association of pravastatin and left ventricular mass in hypercholesterolemic patients: role of 8-iso-prostaglandin f2alpha formation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153644-S0-000000000-00000

10.2165/1153644-S0-000000000-00000

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

24 August 2017

1007845006

0 references

Fatcat ID

release_5mjsnldcwbdvdok2oh5hclgjim

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5mjsnldcwbdvdok2oh5hclgjim

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference